Download Tools | SOMAVERT® (pegvisomant for injection) | Safety Info

Download tools and educational resources

The Understanding Acromegaly and What to Expect With SOMAVERT Brochure offers brief, useful information about acromegaly—its signs, symptoms, and treatment.

Download the Patient Brochure

A Routine Reference Guide with tips to help you create a successful injection routine.

Download the Routine Reference Guide

Using the Office Visit Preparedness Guide can help you feel more prepared the next time you talk with your healthcare provider.

Download the Office Visit
Preparedness Guide

The Packaging and Storage Flash Card compares packaging options and gives instructions on how to store SOMAVERT either in the refrigerator or at room temperature.

Download the Packaging
and Storage Flash Card

The Patient Insurance Roadmap can help guide patients with acromegaly through the insurance process.

Download the Patient Insurance Roadmap

The SOMAVERT Injection Placemat contains easy-to-follow, step-by-step instructions that you can refer to anytime for a quick reminder on how to perform your injection.

Download the SOMAVERT Injection Placemat

The What to Expect Tear Pad is a quick, easy way to remind yourself about information on either acromegaly or SOMAVERT.

Download the What to Expect Tear Pad

The Stay on Track With SOMAVERT Mini-Booklet provides an inside look at some of the ways the Stay on Track With SOMAVERT program can help you manage your acromegaly.

Download the Stay on Track With SOMAVERT Mini-Booklet

Questions about medicine side effects should be directed to Pfizer (1-800-438-1985).

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.

Remember: You can call the Device Support Hotline (1-800-645-1280) if you have questions about the proper administration of SOMAVERT.

content-footer

IMPORTANT SAFETY INFORMATION

Click to expand

Do not use SOMAVERT^® (pegvisomant for injection) if you are allergic to SOMAVERT or anything that is in it.

Be sure to tell your doctor if you use narcotic painkillers (opioid medicines) because the dose of SOMAVERT may need to be changed.

Blood sugar levels may go down when taking SOMAVERT. Be sure to tell your doctor if you use insulin or other medicines (oral hypoglycemic medicines) for diabetes. The dose of these medicines may need to be reduced when you use SOMAVERT.

Some people who have used SOMAVERT have developed liver problems. These problems generally disappeared when those people stopped taking SOMAVERT.

Stop the drug right away and call your doctor if you get any of these symptoms:

Your skin or the white part of your eyes turns yellow (jaundice)
Your urine turns dark
Your bowel movements (stools) turn light in color
You do not feel like eating for several days
You feel sick to your stomach (nausea)
You have unexplained tiredness
You have pain in the stomach area (abdomen)

Your doctor may do blood tests before and during your treatment with SOMAVERT to check that the IGF-1 levels in your blood are normal and/or that your liver is working correctly. Your dose of SOMAVERT may be changed based on the results of these tests.

If you have stopped SOMAVERT because of an allergic reaction, your doctor will carefully monitor what happens if you start SOMAVERT again.

The most common side effects with SOMAVERT are infection, pain, nausea, diarrhea, abnormal liver function tests, flu-like symptoms, and reaction at the injection site. These are not all of the possible side effects of SOMAVERT. For more information, speak to your doctor.

Inject SOMAVERT in a different place on your body each day. This can help prevent skin problems such as lumpiness or soreness.

SOMAVERT has not been studied in pregnant women. It is not known if SOMAVERT passes into the mother’s milk or if it can harm the baby.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.

INDICATION

SOMAVERT is a prescription medicine for acromegaly. It is for patients whose disease has not been controlled by surgery or radiation, or patients for whom these options are not appropriate. The goal of treatment with SOMAVERT is to have a normal IGF-1 level in the blood.

This site is intended only for U.S residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

ISI